Literature DB >> 7627953

Aberrant expression of the growth factor Wnt-5A in human malignancy.

R V Iozzo1, I Eichstetter, K G Danielson.   

Abstract

The Wnt-5A gene codes for a secreted cysteine-rich growth factor that mediates cell to cell signaling via a paracrine mechanism during development and ontogeny. We have recently determine the genomic organization and chromosomal mapping of the human Wnt-5A, and observed distinct patterns of expression in developing human embryos. In this report, we have performed a detailed expression analysis of 100 adult human tissues and tumors and 10 human cell lines. Our data show a widespread expression of Wnt-5A in adult tissues and cells, and aberrant mRNA levels in lungs, breast, and prostate carcinomas and in melanomas. The up-regulation of Wnt-5A in human malignancy was not due to either gene rearrangement or amplification. These findings document an abnormal expression of this growth factor in malignancy and implicate Wnt-5A in the genesis of human cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627953

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

Review 1.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

2.  Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

Authors:  B A Alman; C Li; M E Pajerski; S Diaz-Cano; H J Wolfe
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Exendin-4 promotes pancreatic β-cell proliferation via inhibiting the expression of Wnt5a.

Authors:  Xinger Wu; Weiwei Liang; Hongyu Guan; Juan Liu; Liehua Liu; Hai Li; Xiaoying He; Jing Zheng; Jie Chen; Xiaopei Cao; Yanbing Li
Journal:  Endocrine       Date:  2016-11-09       Impact factor: 3.633

4.  Differential regulation of the mouse and human Wnt5a alternative promoters A and B.

Authors:  Karen S Katula; Nicole B Joyner-Powell; Chia-Chi Hsu; Amber Kuk
Journal:  DNA Cell Biol       Date:  2012-10-09       Impact factor: 3.311

5.  WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer.

Authors:  Hirohide Yoshikawa; Kenichi Matsubara; Xiaoling Zhou; Shu Okamura; Takahiko Kubo; Yaeko Murase; Yuko Shikauchi; Manel Esteller; James G Herman; Xin Wei Wang; Curtis C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

6.  Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.

Authors:  K Pham; T Milovanovic; R J Barr; T Truong; R F Holcombe
Journal:  Mol Pathol       Date:  2003-10

7.  WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.

Authors:  Waleerat Sukarawan; Darrin Simmons; Cynthia Suggs; Kimberly Long; J Timothy Wright
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 8.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Authors:  Yarí E Marín; Suzie Chen
Journal:  J Mol Med (Berl)       Date:  2004-08-21       Impact factor: 4.599

Review 9.  The complex pathways of Wnt 5a in cancer progression.

Authors:  Tobias Pukrop; Claudia Binder
Journal:  J Mol Med (Berl)       Date:  2007-10-19       Impact factor: 4.599

10.  A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.

Authors:  Qin Wang; Andrew J Symes; Corrina A Kane; Alex Freeman; Joseph Nariculam; Philippa Munson; Christopher Thrasivoulou; John R W Masters; Aamir Ahmed
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.